CLINICAL_TRIALS
trial_result
· 2025-12-19
Clinical Trial Update: TOLER-ENT Study: A Study to Investigate the Tolerance of the High Energy, High Protein Formula Sondalis® HP 2 kcal [NA]
Summary
The TOLER-ENT study evaluating the tolerance of the high energy, high protein formula Sondalis HP 2 kcal in malnutrition was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Société des Produits Nestlé (SPN) | Conditions: Malnutrition | NA | Status: TERMINATED